Connect your AI

MeiraGTx Holdings plc MGTX Long-Term Debt

Long-Term Debt at other companies

Regeneron PharmaceuticalsREGN

$1.99B+0.1%

Zevra Therapeutics, Inc.ZVRA

$0-100%

Beam TherapeuticsBEAM

$100.19M—

Recursion Pharmaceuticals, Inc.RXRX

$7.18M-56.3%

Halozyme TherapeuticsHALO

$1.94B+28.4%

Other financials

Income statement

Revenue$293.0K-84.8%

Operating income-$40.8M+1.9%

Net income-$46.3M-15.8%

EPS (diluted)-$0.57-11.8%

Balance sheet

Cash & equivalents$71.5M+7.5%

Total debt$62.7M-22.5%

Total equity-$58.1M-276%

Total assets$244.7M+9.2%

Cash flow

Operating cash flow$17.8M+148%

CapEx$2.0M+17.4%

Free cash flow$15.8M+141%

Valuation

Market cap$1.07B+111%

Enterprise value$1.07B+103%

P/S13.5×-1.3×

Profitability

Operating margin-597.9%-207pp

Net margin-615.3%—

FCF margin-441.5%-126pp

Returns & leverage

Return on equity-379.5%—

Debt / equity27.2×+26.1×

Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:LongTermNotesPayable.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is MeiraGTx Holdings plc's long-term debt?: MeiraGTx Holdings plc (MGTX) reported long-term debt of $49.7M in Q1 2026.
How has MeiraGTx Holdings plc's long-term debt changed year-over-year?: MeiraGTx Holdings plc's long-term debt decreased by 32.4% year-over-year, from $73.5M to $49.7M.
What is the long-term trend for MeiraGTx Holdings plc's long-term debt?: Over 4 years (2021 to 2025), MeiraGTx Holdings plc's long-term debt has grown at a 168.7% compound annual growth rate (CAGR), from $953K to $49.69M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.